ClinicalTrials.Veeva

Menu

QDOT Based PVI for Atrial Fibrillation Treatment - The peQasus Study

U

University of Luebeck

Status

Not yet enrolling

Conditions

Atrial Fibrillation

Treatments

Device: pulmonary vein isolation

Study type

Observational

Funder types

Other

Identifiers

NCT05710822
peQasus study

Details and patient eligibility

About

PeQasus is a worldwide, retrospective, multicenter analysis focusing on QDOT based PVI. Data of at least 300 patients with QDOT based PVI will be collected. All data will be evaluated after anonymization. Primary endoints are efficacy and safety.

Enrollment

300 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Suitable for PVI

Exclusion criteria

  • Non suitable for PVI

Trial contacts and locations

0

Loading...

Central trial contact

Christian-Hendrik Heeger, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems